These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
2,251 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Philips North America recalled 1,913,441 IntelliVue Multi Measurement Servers on October 31, 2025. These devices may fail to alarm, posing a serious risk to patient safety. Users should stop using the device immediately and follow recall instructions.
Philips recalled 1,913,441 IntelliVue MP40 monitors on October 31, 2025, due to a failure to alarm. This defect poses a high risk to patient safety. The recall affects devices distributed worldwide, including in the US.
Philips North America recalled 1,913,441 IntelliVue MP80 monitors on October 31, 2025. The devices may fail to alarm, presenting a high risk to patient safety. Healthcare providers and patients should stop using the monitors immediately.
Philips North America recalled 1,913,441 IntelliVue MP50 monitors on October 31, 2025. The monitors may fail to alarm, posing a high risk to patient safety. Healthcare providers must stop using the devices immediately and follow recall instructions.
Philips North America recalled 1,913,441 IntelliVue MP2 monitors on October 31, 2025. The monitors may not alarm as intended, posing a risk to patient safety. Affected devices were distributed worldwide, including the United States and multiple countries.
Potential issue where the IntelliVue monitors did not alarm.
Philips Ultrasound recalled 4,819 diagnostic ultrasound systems on October 31, 2025. The recall affects models 795005, 795161, and 989605449841 due to compatibility issues with Apple devices running iOS 18. These issues may prevent the systems from performing live imaging, posing risks in medical settings.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. The monitors may fail to alarm, posing serious risks to patients. Users must stop using the device immediately and follow the manufacturer's instructions.
Dynarex Corporation recalled 2,592 bottles of WeCare Zinc Oxide Ointment on October 31, 2025, due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the ointment immediately and seek guidance.
Dynarex Corporation recalled 8,184 bottles of Dynagel Moisturizing Wound Hydrogel on October 31, 2025. The recall follows deviations from current Good Manufacturing Practices (cGMP). Consumers should stop using the product immediately and consult healthcare providers for guidance.
Blossom Pharmaceuticals recalled 9,600 containers of Lanashield Skin Barrier on October 31, 2025 due to cGMP deviations. Consumers and healthcare providers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Trifecta Pharmaceuticals USA recalled 12,150 bottles of Globe Clotrimazole Cream on October 31, 2025. The recall stems from deviations in current Good Manufacturing Practices (cGMP). Consumers should stop using the cream immediately and contact their healthcare providers.
Nivagen Pharmaceuticals recalled 7,920 bottles of Zinc Oxide Ointment on October 31, 2025. The recall follows cGMP deviations that could impact product safety. Consumers should cease use immediately and consult healthcare providers for advice.
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
Dyrnarex Corporation recalled 1,560 containers of Dynashield Skin Protectant on October 31, 2025. The product may not meet current Good Manufacturing Practice standards. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Philips North America recalled 1,913,441 IntelliVue MP30 monitors on October 31, 2025. The devices may fail to alarm, posing a serious risk to patients. Users must stop using the monitors and follow recall instructions immediately.
Philips North America recalled 1,913,441 IntelliVue MP90 monitors on October 31, 2025. The monitors may fail to alarm, posing a high risk to patient safety. Users must stop using the devices immediately and follow manufacturer instructions for remedy.
Trifecta Pharmaceuticals recalled 14,700 bottles of Globe Clotrimazole Cream USP on October 31, 2025, due to significant cGMP deviations. The affected product may not meet necessary safety and quality standards. Consumers should stop using the cream immediately and seek guidance from healthcare providers.
Cipla USA recalled 4,438 cartons of Phytonadione Injectable Emulsion on October 31, 2025. The product failed stability specifications, raising concerns about its safety. Consumers and healthcare providers must stop using the product immediately and seek guidance.
Dynashield, a 4 oz cream, is recalled after cGMP deviations were identified. The recall affects 7,944 units distributed nationwide. Consumers should stop using the product immediately and contact their healthcare provider for guidance.